Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System.
Saved in:
| Title: | Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System. |
|---|---|
| Authors: | Beaudry FEG; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada., Li Z; Toronto General Hospital, Toronto, ON M5G 2C4, Canada., Borgida A; Toronto General Hospital, Toronto, ON M5G 2C4, Canada., Zorigtbaatar A; Toronto General Hospital, Toronto, ON M5G 2C4, Canada.; Department of Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada., Wang X; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.; Eliot Phillipson Clinician-Scientist Training Program, University of Toronto, Toronto, ON M5S 3H2, Canada., Hildebrand M; Toronto General Hospital, Toronto, ON M5G 2C4, Canada., Hamza O; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada., Jang GH; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada., Bucur R; Toronto General Hospital, Toronto, ON M5G 2C4, Canada., Dodd A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada., Wilson J; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada., Auer RC; Ottawa Hospital Research Institute, Ottawa, ON K1Y 1J8, Canada., Saibil S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada., Tsang ES; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada., Vogel A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.; Toronto General Hospital, Toronto, ON M5G 2C4, Canada.; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany., O'Kane GM; St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin D04 T6F4, Ireland., Gallinger S; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Department of Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada., Knox JJ; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada., Notta F; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2C4, Canada., Sapisochin G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.; Toronto General Hospital, Toronto, ON M5G 2C4, Canada.; Department of Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada., Grant RC; Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON M5G 2C4, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON M4N 3M5, Canada. |
| Source: | Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Jan 31; Vol. 32 (2). Date of Electronic Publication: 2025 Jan 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1718-7729 |
|---|---|
| DOI: | 10.3390/curroncol32020080 |
